VTRS Dividend Calculator

VTRS paid $0.48 per share over the last twelve months against a share price of $17.42, which is where the 2.76% comes from. Special and one-off distributions are excluded from that figure — they do not recur, and including them would overstate every projection below.

A yield close to the market median is the least informative figure on this page — it is what most payers look like. What separates VTRS from the rest of that group is the schedule it pays on, the record behind the payment and what funds it, covered below.

Healthcare dividends compete for the same cash as research spending, which is why yields in the sector are typically modest even at large companies. The sector-specific risk to the payment is patent expiry: revenue concentrated in one or two products can step down sharply rather than decline gradually.

VTRS pays quarterly, the standard schedule for US-listed payers, so the "per payment" column is one quarter of the annual figure and the "monthly average" column is a smoothed figure rather than a description of when cash arrives — nothing is paid in eight months of the year.

Each payment has an ex-dividend date, and it is the date that governs entitlement: shares bought on or after it do not carry that payment. VTRS's full schedule and payment history are on its dividend page.

VTRS's payout ratio is negative, which means the dividend is being paid while the company reports a loss. A dividend can be funded from cash reserves or borrowing through a loss-making period, but not from profits that do not exist — and every projection above assumes the current payment continues indefinitely.

The figures hold the dividend flat. No multi-year record of consecutive increases is on file for VTRS, so treat the projection as arithmetic on today's payment rather than as an expectation about future ones.